HomeMedication lookupDrug classes › SSRI antidepressants
SSRIs

SSRI antidepressants and pharmacogenetics

Also known as: Selective Serotonin Reuptake Inhibitors

6 medications 6 brand products CYP2C19CYP2D6

Why pharmacogenetics matter for ssri antidepressants

SSRIs (selective serotonin reuptake inhibitors) are the most-prescribed antidepressant class, used for major depression, anxiety disorders, PTSD, OCD, and premenstrual dysphoric disorder. Most SSRIs are cleared by CYP2C19, CYP2D6, or a mix of both. Because these enzymes vary widely across the population, how fast someone clears an SSRI can swing plasma levels twofold or more, which is a big part of why two people on the same drug at the same dose can have very different experiences.

CYP2C19 pharmacogenetics are especially relevant for citalopram, escitalopram, and sertraline. CPIC publishes dose recommendations for all three based on CYP2C19 phenotype, and the FDA has specific dose caps for citalopram in CYP2C19 poor metabolizers.

Key genes in this class

Medications in this class with pharmacogenetic guidelines

Each link goes to the drug's full pharmacogenetics page with CPIC and FDA phenotype recommendations.

Brand products in the SSRIs class

Combined products and brand names for the medications above. Each links to a pharmacogenetic breakdown.

Which ssris is right for your genetics?

This page covers the pharmacogenetics of ssri antidepressants in general. A Gene2Rx report tells you how your personal genotype interacts with every drug on this page.

Get your report Look up a medication

Informational only, not medical advice. Pharmacogenetic guidelines describe population-level patterns that inform prescribing decisions. Never start, stop, or change a medication without talking to your prescribing clinician.

Get Your Report Now
Ready in One Minute